GlaxoSmithKline Pharmaceuticals fell 1.84% to Rs 3,234.10 at 9:54 IST on BSE after net profit fell 25.35% to Rs 96.05 crore on 6.52% decline in total income to Rs 731.43 crore in Q2 September 2015 over Q2 September 2014.
The result was announced on Saturday, 31 October 2015.
Meanwhile, the BSE Sensex was down 133.86 points, or 0.50%, to 26,522.97.
On BSE, so far 737 shares were traded in the counter, compared with an average volume of 2,763 shares in the past one quarter.
The stock hit a high of Rs 3,266.50 and a low of Rs 3,222.20 so far during the day. The stock hit a record high of Rs 3,825 on 5 August 2015. The stock hit a 52-week low of Rs 2,681 on 3 November 2014.
The stock had underperformed the market over the past one month till 30 October 2015, falling 1.34% compared with 1.92% rise in the Sensex. The scrip had also underperformed the market in past one quarter, sliding 6.52% as against Sensex's 3.78% decline.
The large-cap company has an equity capital of Rs 84.70 crore. Face value per share is Rs 10.
GlaxoSmithkline Pharmaceuticals is engaged in the business of manufacturing, distributing and trading in pharmaceuticals.
Powered by Capital Market - Live News
